Literature DB >> 11687146

Oral steroids for bronchiectasis (stable and acute exacerbations).

T Lasserson1, K Holt, M Greenstone.   

Abstract

BACKGROUND: Inflammation plays a significant role in the pathophysiology of bronchiectasis. Two small studies have shown small benefits from inhaled corticosteroids and oral corticosteroids may be of benefit in bronchiectasis
OBJECTIVES: To determine the efficacy of oral corticosteroids in acute and stable bronchiectasis SEARCH STRATEGY: The Cochrane Airways Group clinical trials register, derived from MEDLINE, EMBASE and hand searching of major journals, was searched using the terms bronchiectasis AND corticosteroid* OR (beclomethasone, cortisone, deflazacort, hydrocortisone, methylprednisolone, prednisolone, dexamethasone and triamcinolone SELECTION CRITERIA: Only randomised controlled trials were considered DATA COLLECTION AND ANALYSIS: No trials met the inclusion criteria for the review MAIN
RESULTS: No randomised controlled trials were identified REVIEWER'S
CONCLUSIONS: There are no randomised trials upon which to make recommendations about the use of oral corticosteroids in acute or stable bronchiectasis.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11687146     DOI: 10.1002/14651858.CD002162

Source DB:  PubMed          Journal:  Cochrane Database Syst Rev        ISSN: 1361-6137


  13 in total

1.  Shoring up professionalism. Building on disagreements between residents and attending physicians.

Authors:  G Caleb Alexander; Horace M Delisser; John Hansen-Flaschen; John D Lantos
Journal:  Can Fam Physician       Date:  2006-03       Impact factor: 3.275

Review 2.  Treatment of bronchiectasis in adults.

Authors:  Nick H T ten Hacken; Peter J Wijkstra; Huib A M Kerstjens
Journal:  BMJ       Date:  2007-11-24

Review 3.  Interventions for bronchiectasis: an overview of Cochrane systematic reviews.

Authors:  Emma J Welsh; David J Evans; Stephen J Fowler; Sally Spencer
Journal:  Cochrane Database Syst Rev       Date:  2015-07-14

4.  Could vitamin d have a potential anti-inflammatory and anti-infective role in bronchiectasis?

Authors:  Jim Bartley; Jeff Garrett; Cameron C Grant; Carlos A Camargo
Journal:  Curr Infect Dis Rep       Date:  2013-04       Impact factor: 3.725

Review 5.  Severe bronchiectasis.

Authors:  Brian M Morrissey; Samuel J Evans
Journal:  Clin Rev Allergy Immunol       Date:  2003-12       Impact factor: 8.667

Review 6.  An integrative review of systematic reviews related to the management of breathlessness in respiratory illnesses.

Authors:  Chris D Bailey; Richard Wagland; Rasha Dabbour; Ann Caress; Jaclyn Smith; Alex Molassiotis
Journal:  BMC Pulm Med       Date:  2010-12-09       Impact factor: 3.317

7.  Longitudinal medical records as a complement to routine drug safety signal analysis.

Authors:  Kristina Star; Sarah Watson; Lovisa Sandberg; Jeanette Johansson; I Ralph Edwards
Journal:  Pharmacoepidemiol Drug Saf       Date:  2015-01-27       Impact factor: 2.890

8.  The Saudi Thoracic Society guidelines for diagnosis and management of noncystic fibrosis bronchiectasis.

Authors:  Hamdan Al-Jahdali; Abdullah Alshimemeri; Abdullah Mobeireek; Amr S Albanna; Nehad N Al Shirawi; Siraj Wali; Khaled Alkattan; Abdulrahman A Alrajhi; Khalid Mobaireek; Hassan S Alorainy; Mohamed S Al-Hajjaj; Anne B Chang; Stefano Aliberti
Journal:  Ann Thorac Med       Date:  2017 Jul-Sep       Impact factor: 2.219

Review 9.  The Likelihood of Preventing Respiratory Exacerbations in Children and Adolescents with either Chronic Suppurative Lung Disease or Bronchiectasis.

Authors:  Kerry-Ann F O'Grady; Keith Grimwood
Journal:  Front Pediatr       Date:  2017-03-24       Impact factor: 3.418

10.  Inhaled Corticosteroid Therapy in Bronchiectasis is Associated with All-Cause Mortality: A Prospective Cohort Study.

Authors:  Kjell E J Håkansson; Katrine Fjaellegaard; Andrea Browatzki; Melda Dönmez Sin; Charlotte Suppli Ulrik
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2021-07-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.